Faba Bean-Enriched Foods for Diabetes and Obesity

N/A

Waitlist Available

Led By Harvey G Anderson, PhD

Research Sponsored by University of Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

No metabolic disease

Male

Must not have

Currently taking appetite-modifying medications

Timeline

Screening 3 weeks

Treatment Varies

Follow Up starting at the beginning of each session (0 minutes, before consumption of treatment) and every 15 - 30 minutes up to 200 minutes (time of completion of each session)

Awards & highlights

No Placebo-Only Group

Summary

This trial found that adding faba bean to crackers or pasta may reduce blood glucose and food intake.

Who is the study for?

This trial is for non-smoking men aged 18-30 with a BMI between 20 and 25, who do not have metabolic diseases or intolerances to treatments. It's not suitable for those on appetite-modifying meds, with restrictive eating habits, who skip breakfast, or are over/underweight.

What is being tested?

The study tests if crackers/pasta enriched with faba bean components (protein concentrate/isolate, flour, starch) can lower blood sugar response and reduce food intake compared to products without these ingredients.

What are the potential side effects?

Potential side effects may include digestive discomfort due to the high fiber content in faba beans. However, since this is a food-based intervention rather than medication, severe side effects are unlikely.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I do not have a metabolic disease.

Select...

I am male.

Select...

I am between 18 and 30 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am currently on medication that affects my appetite.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ starting at the beginning of each session (0 minutes, before consumption of treatment) and every 15 - 30 minutes up to 200 minutes (time of completion of each session)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~starting at the beginning of each session (0 minutes, before consumption of treatment) and every 15 - 30 minutes up to 200 minutes (time of completion of each session)

This trial's timeline: 3 weeks for screening, Varies for treatment, and starting at the beginning of each session (0 minutes, before consumption of treatment) and every 15 - 30 minutes up to 200 minutes (time of completion of each session) for reporting.